Browse by CV

Up a level
Export as [feed] Atom [feed] RSS

HURST, L. A., BUNNING, R. A. D., COURAUD, P.-O., ROMERO, I. A., WEKSLER, B. B., SHARRACK, B. and WOODROOFE, M. N. (2009). Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. Journal of neuroimmunology, 210 (1-2), 108-112.

REID, M. J., CROSS, A. K., HADDOCK, G., ALLAN, S. M., STOCK, C. J., WOODROOFE, M. N., BUTTLE, D. J. and BUNNING, R. A. D. (2009). ADAMTS-9 expression is up-regulated following transient middle cerebral artery occlusion (tMCAo) in the rat. Neuroscience letters, 452 (3), 252-257.

TURNER, S. L., BLAIR ZAJDEL, M. E. and BUNNING, R. A. D. (2009). ADAMs and ADAMTSs in cancer. British journal of biomedical science, 66 (2), 117-128.

CROSS, A. K., HADDOCK, G., STOCK, C. J., ALLAN, S., SURR, J., BUNNING, R. A., BUTTLE, D. J. and WOODROOFE, N. (2006). ADAMTS -1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes. Brain research, 1088 (1), 19-30.

MBVUNDULA, E. C., BUNNING, R. A. D. and RAINSFORD, K. D. (2005). Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1α-induced matrix degradation in bovine articular chondrocytes in-vitro. Journal of pharmacy and pharmacology, 58 (3), 351-358.

PLUMB, J., MCQUAID, S., CROSS, A. K., SURR, J., HADDOCK, G., BUNNING, R. A. D. and WOODROOFE, M. N. (2005). Upregulation of ADAM-17 expression in active lesions in multiple sclerosis. Multiple Sclerosis, 12 (4), 375-385.

MBVUNDULA, E. C., BUNNING, R. A. D. and RAINSFORD, K. D. (2004). Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage. Biochemical pharmacology, 69 (4), 635-640.

GODDARD, D. R., BUNNING, R. A. D. and WOODROOFE, M. N. (2001). Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia, 34 (4), p. 267.

This list was generated on Tue Jul 7 12:30:36 2020 UTC.